|
|
Office Locations:
|
Four Embarcadero Center, Suite 3720
San Francisco, CA 94111
Phone: 650-234-1200
Fax: 650-234-1250
| | |
|
|
|
|
|
Life Sciences & Healthcare
Medical Device
|
|
|
|
Founded in 1993, Montreux Growth Partners is a venture capital firm focused on pharmaceutical and medical device companies. Montreux is currently investing out of its fourth fund, MEP IV, a $250 million fund. Montreux's investment ranges from $10-$20 million per company. Montreux typically invests in the first institutional capital raising of clinical and commercialization stage companies. At the time of investment, a company will typically have $10 to $100 million in annual revenue. Montreux typically invests $10 to $20 million per company
|
|
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
